YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α

Positive evidence from clinical trials has fueled growing acceptance of traditional Chinese medicine (TCM) for the treatment of cardiac diseases; however, little is known about the underlying mechanisms. Here, we investigated the nature and underlying mechanisms of the effects of YiXin-Shu (YXS), an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yichao, Xu, Longwei, Qiao, Zhiqing, Gao, Lingchen, Ding, Song, Ying, Xiaoying, Su, Yuanyuan, Lin, Nan, He, Ben, Pu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786861/
https://www.ncbi.nlm.nih.gov/pubmed/26964694
http://dx.doi.org/10.1038/srep23025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786861/
https://www.ncbi.nlm.nih.gov/pubmed/26964694
http://dx.doi.org/10.1038/srep23025

Ejemplares similares